Roy Hertz, M.D. (1909–2002): The cure of choriocarcinoma and its impact on the development of chemotherapy for cancer Jonathan P Yarris, B.S., Alan J Hunter, M.D. Gynecologic Oncology Volume 89, Issue 2, Pages 193-198 (May 2003) DOI: 10.1016/S0090-8258(03)00110-0
Fig. 1 Portrait of Roy Hertz, M.D., ca. 1960. (Courtesy of Roy Hertz, M.D., July 2002.) Gynecologic Oncology 2003 89, 193-198DOI: (10.1016/S0090-8258(03)00110-0)
Fig. 2 Charles Meredith (seated), the first patient admitted to the Clinical Center of the NIH for hormonal evaluation of prostate cancer. Roy Hertz is standing to the rear. (Courtesy of Roy Hertz, M.D., July 2002.) Gynecologic Oncology 2003 89, 193-198DOI: (10.1016/S0090-8258(03)00110-0)